Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 2:53 AM
Ignite Modification Date:
2025-12-25 @ 2:53 AM
NCT ID:
NCT02080533
Eligibility Criteria:
Inclusion Criteria:
* Previous documentation of mean pulmonary artery pressure \> 25 mm Hg with a pulmonary capillary wedge pressure (or left ventricular end-diastolic pressure) \< 16 mm Hg and PVR \> 3 WU at any time before study entry.
* Women with WHO Group I PAH (idiopathic, heritable, or associated with connective tissue disease, congenital heart disease, anorexigens or HIV)
* Targeted PAH therapy at stable dose for 3 months
* Age \>21 years
* Ability to perform six minute walk testing without limitations in musculoskeletal function or coordination.
* Informed consent
Exclusion Criteria:
* Age \< 21
* Hypotension (blood pressure \< 90/60 mmHg)
* Pregnancy
* Chronic Fatigue Syndrome (current or history of)
* Known sleep disorder (obstructive sleep apnea, restless leg syndrome, narcolepsy, current or history of)
* Hospitalized or acutely ill
* Major Depression (current or history of)
* Lung transplant recipient
Healthy Volunteers:
False
Sex:
FEMALE
Minimum Age:
21 Years
Study:
NCT02080533
Study Brief:
Protocol Section:
NCT02080533